Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ: STAA )

17.41 -0.59 (-3.28%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 488,294
Open 17.96
Bid (Size) 17.29 (1)
Ask (Size) 18.17 (1)
Prev. Close 18.00
Today's Range 17.12 - 18.07
52wk Range 13.50 - 52.68
Shares Outstanding 48,333,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
3 Stocks Under $50 in Hot Water
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory

Performance

YTD
-27.76%
-27.76%
1 Month
-23.00%
-23.00%
3 Month
-31.05%
-31.05%
6 Month
-42.56%
-42.56%
1 Year
-53.75%
-53.75%

More News

Read More
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Via StockStory
STAAR Surgical Announces Leadership Transition
From STAAR Surgical Company
Via Business Wire
Analyst Expectations For Staar Surgical's Future
Via Benzinga
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Keep an eye on the top gainers and losers in Wednesday's session.
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
NASDAQ:STAA, a growth stock which is not overvalued.
Via Chartmill
Despite its growth, NASDAQ:STAA remains within the realm of affordability.
Via Chartmill
In the world of growth stocks, NASDAQ:STAA shines as a value proposition.
Via Chartmill
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades
Via Benzinga
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Teradata Posts Weak Revenue, Joins Lyft, Vertiv, Zillow And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
Via Chartmill
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2024 Results
From STAAR Surgical Company
Via Business Wire
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation.
Via Chartmill
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2024 Earnings Conference Call and Webcast on February 19, 2025
From STAAR Surgical Company
Via Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
Investors should take note of NASDAQ:STAA, a growth stock that remains attractively priced.
Via Chartmill
STAAR Surgical to Participate in BTIG Ophthalmology Day
From STAAR Surgical Company
Via Business Wire
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
From STAAR Surgical Company
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.